Easy-Delivery Growth Hormone
Somatropin (recombinant DNA) injection (Novo Nordisk), a prefilled, multi-dose, liquid growth hormone (Norditropin®) in a disposable pen (NordiFlex®) is now available in the U.S. The medication is indicated for the long-term treatment of children with growth failure resulting from inadequate secretion of endogenous growth hormone and for adults with growth hormone deficiency.
esomeprazole 40 mg
NordiFlex® was approved in October 2004. Norditropin® was approved for children in 1997 and for adults in November 2004.
The product is convenient to use; no loading or mixing is required. Fine dosing increments, starting from 0.025 mg, allow patients to set a precise dose to avoid wasting the hormone. A demonstration kit will also be available for health care professionals to teach patients how to administer the injections themselves.
